- Home
- THFF vs EYPT Comparison
THFF vs EYPT Comparison
Compare THFF & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THFF
- EYPT
- Stock Information
- Founded
- THFF 1984
- EYPT 1987
- Country
- THFF United States
- EYPT United States
- Employees
- THFF N/A
- EYPT N/A
- Industry
- THFF Major Banks
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- THFF Finance
- EYPT Industrials
- Exchange
- THFF Nasdaq
- EYPT Nasdaq
- Market Cap
- THFF 599.3M
- EYPT 594.5M
- IPO Year
- THFF N/A
- EYPT 2005
- Fundamental
- Price
- THFF $46.44
- EYPT $7.48
- Analyst Decision
- THFF Hold
- EYPT Strong Buy
- Analyst Count
- THFF 1
- EYPT 8
- Target Price
- THFF $45.00
- EYPT $25.71
- AVG Volume (30 Days)
- THFF 46.6K
- EYPT 922.9K
- Earning Date
- THFF 01-28-2025
- EYPT 03-06-2025
- Dividend Yield
- THFF 4.39%
- EYPT N/A
- EPS Growth
- THFF N/A
- EYPT N/A
- EPS
- THFF 3.68
- EYPT N/A
- Revenue
- THFF $190,119,000.00
- EYPT $45,713,000.00
- Revenue This Year
- THFF N/A
- EYPT N/A
- Revenue Next Year
- THFF $11.50
- EYPT N/A
- P/E Ratio
- THFF $12.61
- EYPT N/A
- Revenue Growth
- THFF N/A
- EYPT 7.50
- 52 Week Low
- THFF $34.58
- EYPT $6.90
- 52 Week High
- THFF $51.87
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- THFF 50.43
- EYPT 44.49
- Support Level
- THFF $42.65
- EYPT $7.15
- Resistance Level
- THFF $46.74
- EYPT $8.25
- Average True Range (ATR)
- THFF 1.12
- EYPT 0.66
- MACD
- THFF 0.14
- EYPT -0.01
- Stochastic Oscillator
- THFF 80.81
- EYPT 22.01
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services, and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.